Gene: TTPA
Official Full Name: alpha tocopherol transfer proteinprovided by HGNC
Gene Summary: This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34899 | TTPA Knockout cell line (HCT 116) | Human | TTPA | 1:2~1:4 | Negative | Online Inquiry |
TTPA Gene Knockout Cell Lines are genetically modified cell models designed to study the specific functions of the TTPA gene, which encodes for the protein alpha-tocopherol transfer protein (α-TTP). These cell lines have been established using advanced CRISPR/Cas9 gene-editing technology, ensuring precise deletion of the TTPA gene. This approach allows researchers to explore the biological pathways influenced by α-TTP, including its role in the transport and metabolism of vitamin E, an essential antioxidant involved in cellular protection and signaling.
The primary function of the TTPA gene knockout cell lines is to facilitate the assessment of cellular responses to oxidative stress, lipid metabolism, and neuroprotective mechanisms. By observing these knockout cell lines, researchers can elucidate the significance of α-TTP in health and disease, particularly in conditions like ataxia, neurodegeneration, and other vitamin E-related disorders. The ability to manipulate these cell lines in vitro provides insights into broader therapeutic strategies and potential interventions for various health conditions.
Scientifically, these knockout cell lines are invaluable tools in both basic and translational research settings, enabling scientists to investigate non-genetic factors influencing vitamin E dynamics. Compared to conventional methods, such as using naturally occurring deficiencies in animal models, TTPA gene knockout cell lines offer controlled environments and reproducibility, allowing for high-throughput screening of potential therapeutic compounds.
Researchers and clinicians can find significant value in utilizing TTPA gene knockout cell lines due to their ability to provide deeper insights into biochemical pathways and genetic regulation. This understanding can lead to developing innovative treatment modalities for disorders linked to vitamin E deficiencies, ultimately enhancing the quality of patient care.
Our company's extensive experience in genetic engineering and commitment to advancing biological research are reflected in the design and reliability of the TTPA Gene Knockout Cell Lines. We strive to provide researchers with cutting-edge tools that power scientific discovery and improve health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.